Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00015626 · ClinicalTrials.gov registry record · Phase 2

A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

A Phase 2 study of Diabetes Mellitus and Insulin Resistance, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
Phase 2
Development phase
300
Enrollment target
1
Study location

NCT00015626 is a Phase 2 study of Diabetes Mellitus and Insulin Resistance that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 300 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00015626, a Phase 2 study of Diabetes Mellitus and Insulin Resistance, has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
Phase 2
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood, and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical trial, we will learn more about the early manifestations of insulin resistance, its treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and in-vitro studies.

Conditions Studied

Diabetes Mellitus Insulin Resistance

Interventions

  • DRUG Metformin
  • PROCEDURE skin biopsy
  • DRUG pioglitazone
  • BEHAVIORAL diet and exercise
  • DRUG rosiglitazone

Study Locations (1)

New York

  • Cornell University - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Phase Phase 2

Sponsor

National Center for Research Resources (NCRR)

94 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00015626

The ClinicalTrials.gov registry entry for NCT00015626 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Metformin is the first listed.

NCT00015626 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00015626 about?

NCT00015626 is a clinical study titled "A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)". The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood, and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical trial, we will learn more about th...

What is the current status of trial NCT00015626?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants.

What conditions does trial NCT00015626 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Insulin Resistance.

What interventions are being tested in trial NCT00015626?

The interventions under investigation include: Metformin (DRUG), skin biopsy (PROCEDURE), pioglitazone (DRUG), diet and exercise (BEHAVIORAL), rosiglitazone (DRUG).

Who is sponsoring clinical trial NCT00015626?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00015626 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Insulin Resistance

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.